Already registered? Sign in to resume walking:

Forgot your password?

INDICATIONS AND USAGE

Sandostatin® LAR Depot (octreotide acetate for injectable suspension) is indicated for patients in whom initial treatment with immediate release Sandostatin® (octreotide acetate) Injection has been shown to be effective and tolerated for:

  • Long-term treatment of the severe diarrhea and flushing episodes associated with metastatic carcinoid tumors.
  • Long-term treatment of the profuse watery diarrhea associated with VIP-secreting tumors.

In patients with carcinoid syndrome and VIPomas, the effect of Sandostatin Injection and Sandostatin LAR Depot on tumor size, rate of growth and development of metastases has not been determined.

IMPORTANT SAFETY INFORMATION

Warnings and precautions: Treatment with Sandostatin LAR Depot may affect gallbladder function, sugar metabolism, thyroid and heart function, and nutritional absorption, which may require monitoring by your doctor.

Before taking Sandostatin LAR Depot: Tell your doctor if you have a history of heart disease or are taking other medications, including: cyclosporine, insulin, oral hypoglycemic agents, beta-blockers, and bromocriptine.

Common side effects: Most patients experience side effects at some time. Some common side effects you may experience include: back pain, fatigue, headache, abdominal pain, nausea, and dizziness.

Other information: Patients with carcinoid tumors and VIPomas should adhere closely to their scheduled return visits for reinjection in order to minimize exacerbation of symptoms.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Read the full Prescribing Information for Sandostatin® LAR Depot.

Read the full Prescribing Information for Sandostatin® Injection.

Each organization has the opportunity to receive up to $10,000 in contributions. Contributions will be based on the number of registered walkers and completed city walks per organization.

Privacy Statement
The personal information you supply to us will be shared with and among our business partners to provide you with products, programs and services regarding cancer and to conduct market research. We do not permit our business partners to use or share your personal information for their own separate marketing purposes. You have the right to unsubscribe at any time by calling 1-888-669-6682. For further information about Novartis privacy practices, please review our privacy policy at www.pharma.us.Novartis.com

 

Join the Community of

iWalkers for Carcinoid

iWalk for Carcinoid is a virtual walkathon to help raise money for carcinoid-related organizations. Taking part in the community is easy. With every virtual footprint, you can iWalk on your own, invite family and friends, or create your own team. You’ll be able to join the fun and donate your time without leaving home, putting on your sneakers, or spending any money. The proud sponsor of this first 3-city iWalk for Carcinoid is Novartis Pharmaceuticals Corporation—the maker of Sandostatin® LAR Depot (octreotide acetate for injectable suspension).

Walk, Learn, and Earn

iWalkers for Carcinoid unite—take your first step today!

  • Register by signing up for the virtual iWalk.
  • Choose the carcinoid organization that you wish to support from your walk.
  • Select your avatar or character who'll walk for you online.
  • Pick your first city, and start walking!
  • Learn and earn points as you go.
standing avatar

Your walk starts here

Just submit your info to participate in the iWalk! Please note that all information is required unless otherwise noted.

Create your iWalk password

headingSeparator

Password must be at least 6 characters and contain at least one lowercase letter, one uppercase letter, and one number.

Check here to display text as you type (if unchecked, anything you type will be hidden by asterisks for your privacy).

Select a donation recipient

headingSeparator

Choose one of the following organizations to support through your participation in the iWalk

Optional: Learn about the Sandostatin Control program

headingSeparator

Sandostatin Control is an educational program designed to help you learn about an approved treatment option for the severe diarrhea and flushing associated with metastatic carcinoid tumors. When you sign up, you’ll get a free Personalized Doctor Discussion Guide along with other supportive materials customized to your individual needs.

Yes! I'd like to learn more about the Sandostatin Control Program.

Treatment with Sandostatin LAR Depot may affect gallbladder function, sugar metabolism, thyroid and heart function, and nutritional absorption, which may require monitoring by your doctor.

Please tell us a little about yourself

headingSeparator

Optional: Join a team

headingSeparator

Did you receive an e-mail invite to join a team?

Joining a team is optional, and you can always join one after you register, but if you'd like to join a team now, just enter the Team Code from the invite:

Optional: Tell your friends about the iWalk!

headingSeparator

Enter your friends' names and e-mail addresses below to invite them to participate in the iWalk. You'll earn points for every friend who registers!

Invite another friend

Opt-In

headingSeparator

I agree to receive marketing information, offers and promotions regarding cancer and also agree that I may be contacted for my opinions regarding products, programs and services. I understand that the information that I provide will be used in accordance with the above Notice and the Novartis Privacy Statement. My consent will remain valid until I unsubscribe.

I would also like to receive information regarding all Novartis Pharmaceuticals Corporation products, programs, and services.

By clicking above, I confirm that I am 18 years or older. You must be at least 18 years of age for Novartis to send you materials.